IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis
Authors:
- Stefan WoehrlSWStefan Woehrl
- Cezmi A. AkdisCACezmi A. Akdis
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 125 (4) , 858-865.e10
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10Immunology, 2009
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cellsJournal of Allergy and Clinical Immunology, 2009
- IL-32–dependent effects of IL-1β on endothelial cell functionsProceedings of the National Academy of Sciences, 2009
- Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK functionProceedings of the National Academy of Sciences, 2008
- Epithelial overexpression of interleukin-32α in inflammatory bowel diseaseClinical and Experimental Immunology, 2007
- Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent MechanismPLOS Medicine, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisJournal of Clinical Investigation, 2000
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Journal of Clinical Investigation, 1994